Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-Modulated Short Term Radiation Therapy (5x5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients With Primarily Resectable Pancreatic Cancer - NEOPANC

NCT01372735 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT01372735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01372735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-Modulated Short Term Radiation Therapy (5x5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients With Primarily Resectable Pancreatic Cancer - NEOPANC
Lead sponsor
University Hospital Heidelberg
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2011
Completion date
August 31, 2017
Enrollment
46 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasms